Victory Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
8,281
-60,109
| -88% | -$18.2M | ﹤0.01% | 1526 |
|
|
2025
Q1 | $22.7M | Sell |
68,390
-2,245
| -3% | -$744K | 0.02% | 768 |
|
|
2024
Q4 | $21.8M | Buy |
70,635
+68,343
| +2,982% | +$21.1M | 0.02% | 811 |
|
|
2024
Q3 | $486K | Buy |
2,292
+40
| +2% | +$8.49K | ﹤0.01% | 2009 |
|
|
2024
Q2 | $631K | Buy |
2,252
+124
| +6% | +$34.7K | ﹤0.01% | 1904 |
|
|
2024
Q1 | $568K | Buy |
2,128
+208
| +11% | +$55.5K | ﹤0.01% | 1941 |
|
|
2023
Q4 | $444K | Buy |
1,920
+499
| +35% | +$115K | ﹤0.01% | 2027 |
|
|
2023
Q3 | $208K | Sell |
1,421
-1,293
| -48% | -$189K | ﹤0.01% | 2196 |
|
|
2023
Q2 | $627K | Sell |
2,714
-159
| -6% | -$36.7K | ﹤0.01% | 1892 |
|
|
2023
Q1 | $696K | Buy |
2,873
+1,475
| +106% | +$357K | ﹤0.01% | 1874 |
|
|
2022
Q4 | $406K | Buy |
+1,398
| New | +$406K | ﹤0.01% | 2075 |
|
|
2020
Q2 | – | Sell |
-3,302
| Closed | -$220K | – | 2949 |
|
|
2020
Q1 | $220K | Buy |
3,302
+1,477
| +81% | +$98.4K | ﹤0.01% | 2303 |
|
|
2019
Q4 | $166K | Buy |
1,825
+354
| +24% | +$32.2K | ﹤0.01% | 2365 |
|
|
2019
Q3 | $127K | Buy |
+1,471
| New | +$127K | ﹤0.01% | 2364 |
|
|
2019
Q2 | – | Sell |
-19,885
| Closed | -$2.49M | – | 1850 |
|
|
2019
Q1 | $2.49M | Buy |
19,885
+6,870
| +53% | +$861K | 0.01% | 1044 |
|
|
2018
Q4 | $1.47M | Sell |
13,015
-180,683
| -93% | -$20.4M | ﹤0.01% | 1113 |
|
|
2018
Q3 | $41.5M | Buy |
193,698
+9,451
| +5% | +$2.02M | 0.09% | 396 |
|
|
2018
Q2 | $51.5M | Sell |
184,247
-18,735
| -9% | -$5.24M | 0.11% | 293 |
|
|
2018
Q1 | $23.7M | Sell |
202,982
-1,224
| -0.6% | -$143K | 0.05% | 545 |
|
|
2017
Q4 | $18.7M | Buy |
204,206
+153,650
| +304% | +$14.1M | 0.04% | 595 |
|
|
2017
Q3 | $2.27M | Buy |
+50,556
| New | +$2.27M | 0.01% | 950 |
|